Juergen Drewe
Oct 6, 2021
Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report
Driessen C, Noppen C, Boonen G, Drewe J. Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report. Clin Case Rep 2021; 9:e04903.
Oct 6, 2021Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report
Oct 6, 2021Clin Case Rep 2021; 9:e04903
Driessen Christoph, Noppen Christoph, Boonen Georg, Drewe Juergen
more
Mar 1, 2017
Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS)
Peterli R, Drewe J, Beglinger C, Schultes B, Schiesser M, Peters T, Borbély Y, Gass M, Nett P, Vetter D, Wölnerhanssen B, Bueter M. Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg 2017; 265:466-473.
Mar 1, 2017Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS)
Mar 1, 2017Ann Surg 2017; 265:466-473
Peterli Ralph, Drewe Juergen, Beglinger Christoph, Schultes Bernd, Schiesser Marc, Peters Thomas, Borbély Yves, Gass Markus, Nett Philipp, Vetter Diana, Wölnerhanssen Bettina Karin, Bueter Marco
more